Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58.
Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of $18.23.
Crocs (CROX) Downgrade by JP Morgan. Falls to $15.53 from 52-week high of $75.21.
Riverbed Technology (RVBD) No big, bad news. Stock down to $13.62 from 52-week high of $52.81.
Verifone (PAY) CFO is out after restatement. Shares drop to $12.65 from 52-week high of $50.
Schering-Plough (SGP) Fitch downgrades after negative comment on key drug product. Falls to $13.91 from 52-week high of $33.81.
Douglas A. McIntyre
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.